Intra-articular AAV-PHP- S mediated chemogenetic targeting of knee-innervating DRG neurons alleviates inflammatory pain in mice
Envoyer une demande de publication

Demande de publication

Merci pour votre intérêt pour nos produits et votre demande concernant cette publication, qui vous sera envoyée si le chercheur et le journal l'autorisent. Notre équipe commerciale vous contactera rapidement.

- Catégories : Arthrite & Arthrose , Articulations , Publications - ID: 1225

S Chakrabarti, LA Pattison, B Doleschall, RH Rickman et al

Department of Pharmacology, University of Cambridge, UK.


Joint pain is the major clinical symptom of arthritis that affects millions of people. Controlling the excitability of knee-innervating dorsal root ganglion (DRG) neurons (knee neurons) by delivering artificial receptors to regulate neuronal activity could potentially provide pain relief. Gene delivery into DRG neurons by injection of adeno-associated virus (AAV) into peripheral organs has had limited success because of the large anatomical distances involved in the periphery. Here we show that the newly engineered serotype, AAV-PHP.S, can deliver functional excitatory (Gq) and inhibitory (Gi) designer receptors activated by designer drugs (DREADDs) into knee neurons of mice to bidirectionally control excitability in vitro, i.e., activated Gq-DREADD increased neuronal excitability while Gi-DREADD decreased neuronal excitability. In vivo, short-term Gq-DREADD activation caused a deficit in motor coordination while Gi-DREADD activation was able to alleviate complete Freund’s adjuvant mediated knee inflammation-induced deficits in digging behavior, a measure of spontaneous pain associated with well-being. This approach may be utilized in translational pain research for peripheral organ specific pain relief.

BIOSEB Instruments Used:
Dynamic Weight Bearing 2.0 (BIO-DWB-DUAL)

Partager ce contenu